-
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary InterventionBrilakis ES, Mashayekhi K, Tsuchikane E et al. -
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting StentsYL Han, B Xu, NeoVas Randomized Controlled Trial Investigators
-
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and CostKwok CS, Rao SV, Potts JE et al.
-
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisM Gaudino, I Hameed, ME Farkouh et al.
-
Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary LookMcIlvennan CK, Morris MA, Guetterman TC et al.
-
Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC GuidelinesRodriguez F, Mahaffey KW.
-
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart AssociationCB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council.
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-upB Bikdeli, MV Madhavan, D Jimenez et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
